NCT00118170
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +83 more
- Locations
-
- Cancer and Leukemia Group B (CALGB) Research Base Chicago, Illinois, United States
Clinical trial condition
Explore clinical trials studying Lymphoma, Large-Cell, Immunoblastic. Study availability and eligibility vary by location and protocol.
NCT00118170
NCT00027560
NCT00004002
NCT00003143
NCT00255749
NCT00296023
NCT00787761
NCT00110045
NCT00003938
NCT00003805